PDIA3 and CACNB2

  • Data Source:
  • BioGRID (affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, proximity labelling technology, affinity chromatography technology)
  • HPRD (in vivo)

PDIA3

CACNB2

Description protein disulfide isomerase family A member 3 calcium voltage-gated channel auxiliary subunit beta 2
Image No pdb structure
GO Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
  • anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
  • Antisaccade task score ( 31596458)
  • Apolipoprotein B levels ( 32203549)
  • Autism spectrum disorder or schizophrenia ( 28540026)
  • Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) ( 23453885)
  • Blood pressure ( 21909110)
  • Body mass index ( 28892062)
  • Brain volume in infants (grey matter) ( 28763065)
  • Cadmium levels ( 26025379)
  • Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
  • Diastolic blood pressure ( 19430479 27841878 21909115 28739976 27618452)
  • Diastolic blood pressure (cigarette smoking interaction) ( 29455858)
  • Diastolic blood pressure x alcohol consumption interaction (2df test) ( 29912962)
  • Diverticular disease ( 30177863)
  • Electrocardiogram morphology (amplitude at temporal datapoints) ( 32916098)
  • Hypertension ( 31879980 19430479 21909115)
  • LDL cholesterol levels ( 32203549)
  • Mean arterial pressure ( 27618448)
  • Mean arterial pressure x alcohol consumption interaction (2df test) ( 29912962)
  • Medication use (agents acting on the renin-angiotensin system) ( 31015401)
  • Medication use (beta blocking agents) ( 31015401)
  • Medication use (calcium channel blockers) ( 31015401)
  • Medication use (diuretics) ( 31015401)
  • Metabolite levels (HVA/MHPG ratio) ( 23319000)
  • Nicotine dependence symptom count ( 25555482)
  • Obesity-related traits ( 23251661)
  • Primary tooth development (number of teeth) ( 23704328)
  • Primary tooth development (time to first tooth eruption) ( 23704328)
  • Protein quantitative trait loci ( 18464913)
  • Pulse pressure ( 30578418)
  • Pulse pressure x alcohol consumption interaction (2df test) ( 29912962)
  • Quantitative traits ( 19197348)
  • Response to antiepileptic drugs in genetic generalized epilepsy ( 32308125)
  • Schizophrenia ( 28991256 25056061 29483656 30285260 23974872)
  • Small vessel stroke ( 26732560)
  • Systolic blood pressure ( 28135244 19430479 27841878 21909115 28739976 27618452 30578418)
  • Systolic blood pressure (cigarette smoking interaction) ( 29455858)
  • Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) ( 29912962)
  • Systolic blood pressure x alcohol consumption interaction (2df test) ( 29912962)
Interacting Genes 21 interacting genes: APP BACE1 CALR CANX ERO1A ERP27 ESR1 GYPC HLA-A IFNG LGALS9 LINC01554 MDM2 MTNR1B PCAT1 SLC12A3 SLC2A1 STAT3 SUMO4 TAP1 UBE3A 6 interacting genes: CTBP2 HEXIM2 PRKACA PRMT5 REM1 TMEM174
Entrez ID 2923 783
HPRD ID 03625 02473
Ensembl ID ENSG00000167004 ENSG00000165995
Uniprot IDs P30101 V9HVY3 A0A494C0B2 A0A494C184 Q08289 Q59H42 Q5VVH1
PDB IDs 2ALB 2DMM 2H8L 3F8U 6ENY
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?